Peptide Libraray

Sequence 4 from Patent US 20070264275

General Information

DCTPep ID DCTPep01292

Peptide Name Sequence 4 from Patent US 20070264275

Sequence GLPPDVQR

Sequence Length 8

UniProt ID Q90611 P50757 P08253

PubChem CID Not available

Origin Homo sapiens

Type Native peptide

Classification

ACP

Activity Information

Hemolytic Activity Not available

Normal (non-cancerous) Cytotoxicity Not available

Target Not available

Affinity Not available

Mechanism Not available

Structure Information

PDB ID Not available

Predicted Structure Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity Not available

Linear/Cyclic Not available

Disulfide/Other Bond Not available

N-terminal Modification Not available

C-terminal Modification Not available

Other Modification None

Chiral L

Physicochemical Information

Formula C38H64N12O12

Absent amino acids ACEFHIKMNSTWY

Theoretical pI 5.84

Acidic residues 1

Basic residues 1

Polar residues 1

Molecular weight (Average) 881

Molecular weight (Monoisotopic) 880.48

Common amino acids P

Net charge 0

Instability index (II) 47.48

Aliphatic index 85.00

Grand average of hydropathicity (GRAVY) -0.887

Half Life
30 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).

Extinction coefficients
Should not be visible by UV spectrophotometry.

Amino acid distribution

Literature Information

Literature 1

Pubmed ID Not available

Title Not available

Doi Not available

Year Not available

Patent

Patent ID US 2007/0264275 A1

Patent Title Peptides Derived from the Protein Mmp-5, and the Use Thereof in Antitumoral Immunotherapy.

Other Iinformation Granted Patent Family: 8s / 8ex; Family Jurisdictions: US, CA, EP, JP, FR, WO; Legal Status: Inactive; Application No: 56195104; Filed:Jun 24, 2004; Published: Nov 15, 2007; Earliest Priority: Jun 25, 2003; Granted: Dec 8, 2009

Other Published ID CA2529943A1 EP1635862A1 US7629439 WO2005000342A1